» Articles » PMID: 35967419

Spindle Pole Body Component 25 and Platelet-derived Growth Factor Mediate Crosstalk Between Tumor-associated Macrophages and Prostate Cancer Cells

Overview
Journal Front Immunol
Date 2022 Aug 15
PMID 35967419
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor-associated macrophages (TAMs) are involved in the growth of prostate cancer (PrC), while the molecular mechanisms underlying the interactive crosstalk between TAM and PrC cells remain largely unknown. Platelet-derived growth factor (PDGF) is known to promote mesenchymal stromal cell chemotaxis to the tumor microenvironment. Recently, activation of spindle pole body component 25 (SPC25) has been shown to promote PrC cell proliferation and is associated with PrC stemness. Here, the relationship between SPC25 and PDGF in the crosstalk between TAM and PrC was investigated. Significant increases in both PDGF and SPC25 levels were detected in PrC specimens compared to paired adjacent normal prostate tissues. A significant correlation was detected between PDGF and SPC25 levels in PrC specimens and cell lines. SPC25 increased PDGF production and tumor cell growth in cultured PrC cells and in xenotransplantation. Mechanistically, SPC25 appeared to activate PDGF in PrC likely through Early Growth Response 1 (Egr1), while the secreted PDGF signaled to TAM through PDGFR on macrophages and polarized macrophages, which, in turn, induced the growth of PrC cells likely through their production and secretion of transforming growth factor β1 (TGFβ1). Thus, our data suggest that SPC25 triggers the crosstalk between TAM and PrC cells SPC25/PDGF/PDGFR/TGFβ1 receptor signaling to enhance PrC growth.

Citing Articles

Integration of single-cell and bulk analysis reveals TBXAS1 as a key platelet-related gene causing poor prognosis in osteosarcoma.

Liu H, Da W, Mu J, He X, Li Z, Gong T Front Genet. 2024; 15:1519529.

PMID: 39720182 PMC: 11667113. DOI: 10.3389/fgene.2024.1519529.


Cancer stem cells: advances in knowledge and implications for cancer therapy.

Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z Signal Transduct Target Ther. 2024; 9(1):170.

PMID: 38965243 PMC: 11224386. DOI: 10.1038/s41392-024-01851-y.


SPC25 as a novel therapeutic and prognostic biomarker and its association with glycolysis, ferroptosis and ceRNA in lung adenocarcinoma.

Liu X, Zhang Y, Ming X, Hu J, Chen X, Wang Y Aging (Albany NY). 2024; 16(1):779-798.

PMID: 38217547 PMC: 10817414. DOI: 10.18632/aging.205418.


The role of angiogenic growth factors in the immune microenvironment of glioma.

Ge Z, Zhang Q, Lin W, Jiang X, Zhang Y Front Oncol. 2023; 13:1254694.

PMID: 37790751 PMC: 10542410. DOI: 10.3389/fonc.2023.1254694.


Platelets promote CRC by activating the C5a/C5aR1 axis via PSGL-1/JNK/STAT1 signaling in tumor-associated macrophages.

Li X, Chen X, Gong S, Zhao J, Yao C, Zhu H Theranostics. 2023; 13(6):2040-2056.

PMID: 37064877 PMC: 10091882. DOI: 10.7150/thno.80555.

References
1.
Jeong J, Keum S, Kim D, You E, Ko P, Lee J . Spindle pole body component 25 homolog expressed by ECM stiffening is required for lung cancer cell proliferation. Biochem Biophys Res Commun. 2018; 500(4):937-943. DOI: 10.1016/j.bbrc.2018.04.205. View

2.
Welti J, Loges S, Dimmeler S, Carmeliet P . Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest. 2013; 123(8):3190-200. PMC: 3726176. DOI: 10.1172/JCI70212. View

3.
Lin L, Chen Y, Yao Y, Chen J, Chen J, Huang S . CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer. Oncotarget. 2015; 6(33):34758-73. PMC: 4741488. DOI: 10.18632/oncotarget.5325. View

4.
Goswami K, Ghosh T, Ghosh S, Sarkar M, Bose A, Baral R . Tumor promoting role of anti-tumor macrophages in tumor microenvironment. Cell Immunol. 2017; 316:1-10. DOI: 10.1016/j.cellimm.2017.04.005. View

5.
Silverman E, Khachigian L, Lindner V, Williams A, Collins T . Inducible PDGF A-chain transcription in smooth muscle cells is mediated by Egr-1 displacement of Sp1 and Sp3. Am J Physiol. 1997; 273(3 Pt 2):H1415-26. DOI: 10.1152/ajpheart.1997.273.3.H1415. View